US FDA News: FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation

Today, the FDA approved a new treatment for Vyondys 53 (golodirsen) injection to treat Duchenne muscular dystrophy (DMD) patients
Read more: FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation